首页> 外文期刊>British journal of ophthalmology >Topical diquafosol for patients with obstructive meibomian gland dysfunction
【24h】

Topical diquafosol for patients with obstructive meibomian gland dysfunction

机译:用于阻塞性睑板腺体功能障碍患者的局部毒脂溶醇

获取原文
获取原文并翻译 | 示例
       

摘要

Aims: To evaluate the effect of topical diquafosol in patients with meibomian gland dysfunction (MGD) using tear film parameters and quantitatively analyse the meibomian gland morphology. Subjects and Methods: The subjects were 19 eyes of 10 patients diagnosed with obstructive MGD. All subjects were given 3% diquafosol ophthalmic solution with instructions to use one drop four times a day. Ocular symptoms were scored from 0 to 14. Lid margin abnormalities were scored from 0 to 4. Changes in the meibomian glands were scored using non-contact meibography (meiboscore). Super ficial punctate keratopathy (SPK) was scored from 0 to 3. Meibum was graded from 0 to 3. Tear film production was evaluated by Schirmer 's test. Quantitative image analysis of the meibomian glands was performed using the original software. Results: 10 patients completed more than 4 months of therapy. Ocular symptoms, lid margin abnormalities, SPK score and meibum grade were decreased. Break-up time and tear film meniscus were increased. Mean ratio of the meibomian gland area was significantly increased after treatment (p<0.0001). Conclusions: Quantitative image analysis was useful for evaluating the morphological changes of the meibomian glands. Topical diquafosol therapy was effective for patients with obstructive MGD.
机译:目的:利用泪膜参数评价局部毒液(MGD)患者局部毒脂醇的影响,并定量分析梅博尼亚腺体形态。受试者和方法:受试者为10名患者诊断患有阻塞性MGD的患者。所有受试者均为3%毒脂溶醇眼科溶液,每天使用一滴4次。从0到14次评分眼镜症状。盖子缘异常被评定为0〜4。使用非接触全经(Meiboscore)评分Meibomian腺体的变化。超级全面点状角病(SPK)被评定为0至3.梅努姆被评分为0到3.沉膜产量通过Schirmer的测试评估。使用原始软件进行Meibomian腺体的定量图像分析。结果:10名患者完成了4个月的治疗。眼部症状,盖子缘异常,SPK评分和梅花级等级降低。分手时间和撕裂薄膜半月板增加。治疗后梅博米腺面积的平均比率显着增加(P <0.0001)。结论:定量图像分析可用于评估睑板腺的形态变化。局部双喹啉疗法对阻塞性MGD的患者有效。

著录项

  • 来源
    《British journal of ophthalmology》 |2013年第6期|共5页
  • 作者单位

    Department of Ophthalmology Itoh Clinic 626-11 Minaminakano Minuma-ku Saitama city Saitama 337;

    Eye Care Company Topcon Corporation Tokyo Japan;

    Eye Care Company Topcon Corporation Tokyo Japan;

    Maeda Ophthalmic Clinic Fukushima Japan;

    Maeda Ophthalmic Clinic Fukushima Japan;

    Eye Care Company Topcon Corporation Tokyo Japan;

    Department of Ophthalmology University of Tokyo School of Medicine Tokyo Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 眼科学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号